scholarly journals Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice

2016 ◽  
Vol 38 (2) ◽  
pp. 233-240 ◽  
Author(s):  
Shi-rong Zhang ◽  
Lu-cheng Zhu ◽  
Yan-ping Jiang ◽  
Jing Zhang ◽  
Ru-jun Xu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Erbb Family ◽  
Erbb Family Blocker

scholarly journals Phase II Study of Afatinib, an Irreversible ErbB Family Blocker, in EGFR FISH-Positive Non–Small-Cell Lung Cancer

2015 ◽  
Vol 10 (4) ◽  
pp. 665-672 ◽  
Author(s):  
Federico Cappuzzo ◽  
Giovanna Finocchiaro ◽  
Francesco Grossi ◽  
Paolo Bidoli ◽  
Adolfo Favaretto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Erbb Family ◽  
Erbb Family Blocker

scholarly journals Abstract 3878: Musashi-2 (MSI2) regulation of ERBB family proteins in non-small cell lung cancer (NSCLC)

2017 ◽  
Author(s):  
Alexander Kudinov ◽  
Alexander Deneka ◽  
Anna N. Nikonova ◽  
Emmanuelle Nicolas ◽  
Vladislav A. Korobeynikov ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Erbb Family

Abstract #829: Effect of Body Mass Index (BMI) and Lipids on Non-Small Cell Lung Cancer (NSCLC) Survival

2016 ◽  
Vol 22 ◽  
pp. 176
Author(s):  
Genevieve Streb ◽  
Narjust Duma ◽  
Natasha Piracha ◽  
Sejal Kothadia ◽  
Komal Patel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Body Mass Index ◽  
Small Cell Lung Cancer ◽  
Body Mass ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document